Royal Bank of Canada’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76K Sell
12,302
-7,005
-36% -$58.2K ﹤0.01% 5280
2025
Q4
$201K Sell
19,307
-475,102
-96% -$4.77M ﹤0.01% 4762
2025
Q3
$4.45M Sell
494,409
-34,817
-7% -$306K ﹤0.01% 2767
2025
Q2
$6.88M Buy
529,226
+52,234
+11% +$785K ﹤0.01% 2316
2025
Q1
$12M Sell
476,992
-31,499
-6% -$936K ﹤0.01% 1627
2024
Q4
$17.5M Buy
508,491
+492,574
+3,095% +$22.2M ﹤0.01% 1438
2024
Q3
$786K Sell
15,917
-692
-4% -$35.5K ﹤0.01% 3734
2024
Q2
$1M Buy
16,609
+8,099
+95% +$463K ﹤0.01% 3458
2024
Q1
$439K Sell
8,510
-3,616
-30% -$177K ﹤0.01% 4062
2023
Q4
$490K Buy
12,126
+8,027
+196% +$235K ﹤0.01% 4285
2023
Q3
$115K Buy
4,099
+1,931
+89% +$57.6K ﹤0.01% 5294
2023
Q2
$62K Sell
2,168
-91
-4% -$2.02K ﹤0.01% 5666
2023
Q1
$37K Sell
2,259
-1,637
-42% -$23.1K ﹤0.01% 5782
2022
Q4
$49K Buy
3,896
+3,645
+1,452% +$44.3K ﹤0.01% 5891
2022
Q3
$3K Buy
251
+135
+116% +$1.85K ﹤0.01% 6918
2022
Q2
$2K Sell
116
-962
-89% -$12.7K ﹤0.01% 6989
2022
Q1
$13K Sell
1,078
-2,568
-70% -$30.8K ﹤0.01% 6839
2021
Q4
$41K Buy
3,646
+1,032
+39% +$12.4K ﹤0.01% 6486
2021
Q3
$33K Buy
+2,614
New +$36K ﹤0.01% 6406

Other funds holding RXST

Royal Bank of Canada's RXST Position: Q1 2026 in Review

Royal Bank of Canada reduced its RxSight (RXST) stake by 36% in Q1 2026, selling an estimated $58.2K and leaving 12,302 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.

Royal Bank of Canada first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Royal Bank of Canada held 12,302 shares of RxSight worth $76K as of Q1 2026.
  • Royal Bank of Canada sold 7,005 RxSight shares in Q1 2026, an estimated $58.2K.
  • RxSight made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5280 holding.
  • Royal Bank of Canada first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's RxSight position peaked at $17.5M in Q4 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.